MedPath

Vanderbilt University

Vanderbilt University logo
🇺🇸United States
Ownership
Private
Established
1873-01-01
Employees
10K
Market Cap
-
Website
http://www.vanderbilt.edu

Autonomic Function in Obstructive Sleep Apnea

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Other: continuous positive airway pressure (CPAP)
First Posted Date
2008-05-21
Last Posted Date
2017-02-24
Lead Sponsor
Vanderbilt University
Target Recruit Count
70
Registration Number
NCT00681161
Locations
🇺🇸

Vanderbilt University, Nashville, Tennessee, United States

Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema

Not Applicable
Completed
Conditions
Fatigue
Breast Cancer
Lymphedema
Interventions
Behavioral: expressive writing
First Posted Date
2008-05-16
Last Posted Date
2017-04-10
Lead Sponsor
Vanderbilt University
Target Recruit Count
107
Registration Number
NCT00679185
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States

Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center

Terminated
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific
First Posted Date
2008-05-02
Last Posted Date
2011-03-24
Lead Sponsor
Vanderbilt University
Registration Number
NCT00670605
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States

Self-Care for Lymphedema in Patients With Breast Cancer

Completed
Conditions
Breast Cancer
First Posted Date
2008-05-02
Last Posted Date
2017-04-10
Lead Sponsor
Vanderbilt University
Target Recruit Count
51
Registration Number
NCT00670644
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

🇺🇸

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States

Antioxidant Systems and Age-Related Macular Degeneration

Completed
Conditions
Macular Degeneration
First Posted Date
2008-04-29
Last Posted Date
2014-01-10
Lead Sponsor
Vanderbilt University
Target Recruit Count
143
Registration Number
NCT00668213
Locations
🇺🇸

Vanderbilt Eye Institute, Nashville, Tennessee, United States

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome

Phase 4
Completed
Conditions
Metabolic Syndrome
Hypertension
Interventions
First Posted Date
2008-04-25
Last Posted Date
2012-05-11
Lead Sponsor
Vanderbilt University
Target Recruit Count
24
Registration Number
NCT00666848
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Retrospective Postoperative ARDS Study at Vanderbilt University

Completed
Conditions
ARDS
First Posted Date
2008-04-10
Last Posted Date
2012-09-07
Lead Sponsor
Vanderbilt University
Target Recruit Count
89
Registration Number
NCT00656071
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED

Not Applicable
Terminated
Conditions
Nausea
Interventions
First Posted Date
2008-04-10
Last Posted Date
2013-10-30
Lead Sponsor
Vanderbilt University
Target Recruit Count
171
Registration Number
NCT00655642
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Omega-3 Fatty Acid Administration in Dialysis Patients

Phase 2
Completed
Conditions
End Stage Renal Disease
Interventions
Dietary Supplement: fish oil
Dietary Supplement: placebo
First Posted Date
2008-04-10
Last Posted Date
2014-04-23
Lead Sponsor
Vanderbilt University
Target Recruit Count
38
Registration Number
NCT00655525
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Corticosteroid Injection as a Predictor of Outcome in Carpal Tunnel Release

Terminated
Conditions
Carpal Tunnel Syndrome
Interventions
Other: Corticosteroid Injection- 1ml of Betamethasone and 1 ml of 1% Lidocaine
First Posted Date
2008-04-10
Last Posted Date
2011-03-09
Lead Sponsor
Vanderbilt University
Target Recruit Count
200
Registration Number
NCT00655915
Locations
🇺🇸

Vanderbilt Hand & Upper Extremity Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath